GlassScriptPhysician profile
Christopher P Chung
NPI 1346441144
$1,792.29
in general payments reported to CMS, 2019-2025
17 companies · $73.00 in 2025
The $73.00 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $24.48 · 2021: $397 · 2022: $350 · 2023: $259 · 2024: $457 · 2025: $73.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $1,134.31 | 2021-2025 | Desara |
| Coloplast Corp | $117.52 | 2019 | |
| Valencia Technologies Corporation | $84.86 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $62.52 | 2019-2024 | Enhertu |
| Abbvie INC. | $60.13 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $54.29 | 2024 | |
| Allergan, INC. | $49.42 | 2019-2020 | |
| Stryker Corporation | $37.32 | 2019 | |
| Axonics, INC. | $24.49 | 2023 | Axonics |
| Medtronic, INC. | $24.31 | 2021 | |
| Immunogen, INC. | $24.27 | 2023 | Elahere |
| Daiichi Sankyo INC. | $23.87 | 2024 | Enhertu |
| Tesaro, INC. | $22.67 | 2019 | |
| Merck Sharp & Dohme LLC | $22.44 | 2024 | Lynparza, Keytruda |
| Glaxosmithkline, LLC. | $19.62 | 2023 | Zejula, Jemperli |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.06 | 2024 | Verzenio |
| Ipsen Biopharmaceuticals, INC | $11.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.